Oral Presentations

Brownell B , Hughes JT. JNNP1962; 25: 315-320

Rovaris M et al. , Am J Neuroradiol2000; 21: 402-408

Geurts JJG et al. , Am J Neuroradiol2005; 26: 572-577

Liu et al. J Neurol Neurosurg Psychiatry1999; 66: 323-330

Rocca MA et al. Neuroimage 2003

Rocca MA et al. Ann Neurol 2003

Reddy H et al. Brain 2002

Schluter ND et al. Brain 1998

Sailer M. et al. Brain 2003

Barkhof F , Elton M , Lindeboom J , Tas MW , Schmidt WF , Hommes OR , Polman CH , Kok A , Valk J. Functional correlates of callosal atrophy in relapsing-remitting multiple sclerosis patients. A preliminary MRI study. J of Neurology1998; 245: 153-158.

Cover KS , Stam CJ , van Dijk BW. Detection of very high correlation in the alpha band between temporal regions of the human brain using MEG. NeuroImage2004; 22: 1432-1437.

Cover KS , Vrenken H , Geurts JJG ,. van Oosten BW , Jelles B , Polman CH , Stam CJ , Dijk BW. Multiple sclerosis patients show a highly significant decrease in alpha band interhemispheric synchronisation measured using MEG. NeuroImage2005; Revision submitted.

Bornstein et al. New Engl J Med1987; 317: 408-414.

Johnson et al. Neurology2004; 62 (suppl 5): A180-A180.

Weinshenker et al. Brain1989; 112: 133-146.

Expert Opinion Paper: Management of MS-Related Fatigue from the Medical Advisory Board of the National Multiple Sclerosis Society available at www.nationalmssociety.org/PRC.asp.

Multiple Sclerosis Council for Clinical Practice Guidelines: Fatigue and Multiple Sclerosis

Pezawas L et al. , J Neurosci2004; 10: 10099-10102.

Egan MF et al. , Cell2003; 112: 257-269.

Castriota-Scanderbeg A. et al. Mult Scler2004; 10: 556-561.

Filippi M. et al. Neurology1995; 45: 478-482.

Kornek B. et al. Am J Pathol2000; 157: 267-276.

Trapp B. D. et al. N Engl J Med1998; 338: 278-285.

Evangelou N. et al. Brain2000; 123: 1845-1849.

Vrenken H. et al. Magn Reson Med2005; 53: 256-266.

Helms G. et al. Magn Reson Med2000; 43: 102-110.

Griffin, C. M. , et al. J Neurol2002; 249: 193-199.

van Walderveen, M. A. , et al. J Magn Reson Imaging2003; 18: 656-664.

Filippi, M. , et al. Mult Scler2004; 10 Suppl 1: S36-S44.

Cercignani et al. , AJNR Am J Neuroradiol2001; 22: 952-958.

Rashid et al. , Mult Scler2004; 10: 9-15.

Rovaris et al. , Arch Neurol2002; 59: 1406-1412.

Amato MP et al. Neurology2004.

Schwid et al , Enhanced benefit of increasing interferon-beta-1a dose and frequency in relapsing MS: the EVIDENCE trial, Arch Neurol2005; 62, 785-792.

Schwarz et al. Journal of Neuroimmunolgy154 (2004) 99-110 abstract 325.

Lolli et al. PNAS July 19, 2005 vol. 102 no. 29 pp 10273-10278.

Filippini G , Brusaferri F , Sibley WA , Citterio A , Midgard R , Candelise L. Corticosteroids or ACTH for acute exacerbations in multiple sclerosis. The Cochrane Database of Systematic Reviews2000, Issue 4: CD001331-CD001331.

Riazi A , Hobart JC , Porter B , Chataway J , Thompson AJ. Developing a measure of patients’ experiences of relapse management in multiple sclerosis. Multiple Sclerosis2003; 9: Suppl 1: S152-S152.